Document:

<PAGE>
                                                                    Exhibit 10.9

            AMENDMENT No. 2 dated as of July 13, 2004 (this "Amendment"), to the
      Amended and Restated Credit Agreement dated as of December 21, 2001, as
      amended by Amendment No. 1 dated as of April 30, 2004 (as may be further
      amended, supplemented or otherwise modified from time to time, the "Credit
      Agreement"), among ENDO PHARMACEUTICALS HOLDINGS INC., a Delaware
      corporation ("Holdings"), ENDO PHARMACEUTICALS INC., a Delaware
      corporation (the "Borrower"), the Lenders party thereto and JPMORGAN CHASE
      BANK, as Administrative Agent.

            A.    The Borrower has requested that the Lenders agree to amend
certain provisions of the Credit Agreement as set forth herein.

            B.    The undersigned Lenders are willing so to amend the Credit
Agreement pursuant to the terms and subject to the conditions set forth herein.

            C.    Capitalized terms used and not otherwise defined herein shall
have the meanings assigned thereto in the Credit Agreement.

            SECTION 1. Amendment to Section 6.04. Section 6.04(l). Section
6.04(l) of the Credit Agreement is hereby amended by deleting such section in
its entirety and replacing it with the following:

                  "(l)  other investments and loans in an aggregate amount not
                  to exceed $55,000,000 at any time outstanding;"

            SECTION 2. Representations and Warranties. Each of Holdings and the
Borrower represents and warrants to the Administrative Agent and to each of the
Lenders that:

            (a)   This Amendment has been duly authorized, executed and
delivered by it and constitutes a legal, valid and binding obligation of such
party hereto, enforceable against it in accordance with its terms.

            (b)   After giving effect to this Amendment, the representations and
warranties set forth in Article III of the Credit Agreement are true and correct
in all material respects on and as of the date hereof with the same effect as if
made on and as of the date hereof, except to the extent such representations and
warranties expressly relate to an earlier date (in which case such
representations and warranties were true and correct as of such earlier date).

            (c)   After giving effect to this Amendment, no Event of Default or
Default has occurred and is continuing.
<PAGE>
            SECTION 3. Conditions to Effectiveness. This Amendment shall become
effective as of the date hereof, when (a) the Administrative Agent shall have
received counterparts of this Amendment that, when taken together, bear the
signatures of Holdings, the Borrower and the Required Lenders, (b) the
representations and warranties set forth in Section 2 hereof are true and
correct and (c) all fees and expenses required to be paid or reimbursed by the
Borrower pursuant hereto, the Credit Agreement or otherwise, including all
reasonable invoiced fees and expenses of counsel to the Administrative Agent,
shall have been paid or reimbursed, as applicable.

            SECTION 4. Credit Agreement. Except as specifically amended hereby,
the Credit Agreement shall continue in full force and effect in accordance with
the provisions thereof as in existence on the date hereof. After the date
hereof, any reference to the Credit Agreement shall mean the Credit Agreement as
amended hereby. This Amendment shall be a Loan Document for all purposes.

            SECTION 5. Applicable Law. THIS AMENDMENT SHALL BE GOVERNED BY, AND
CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK.

            SECTION 6. Counterparts. This Amendment may be executed in two or
more counterparts, each of which shall constitute an original but all of which,
when taken together, shall constitute one agreement. Delivery of an executed
signature page to this Amendment by facsimile transmission shall be effective as
delivery of a manually signed counterpart of this Amendment.

            SECTION 7. Expenses. The Borrower agrees to reimburse the
Administrative Agent for its out-of-pocket expenses in connection with this
Amendment, including the reasonable fees, charges and disbursements of Cravath,
Swaine & Moore LLP, counsel for the Administrative Agent.

            SECTION 8. Headings. The headings of this Amendment are for purposes
of reference only and shall not limit or otherwise affect the meaning hereof.
<PAGE>
            IN WITNESS WHEREOF, the parties hereto have caused this Agreement to
be duly executed by their respective authorized officers as of the day and year
first written above.

                                        ENDO PHARMACEUTICALS
                                        HOLDINGS INC.,

                                        By:   /c/ Jeff Black
                                            ---------------------------
                                        Name: Jeff Black
                                        Title: EVP & CFO

                                        ENDO PHARMACEUTICALS INC.,

                                        By:   /c/ Jeff Black
                                            ---------------------------
                                        Name: Jeff Black
                                        Title: EVP & CFO

                                        JPMORGAN CHASE BANK,
                                        individually and as Administrative
                                        Agent,

                                        By:    /c/ Laura J. Cumming
                                             --------------------------
                                        Name: Laura J. Cumming
                                        Title: Vice President
<PAGE>
                                                                       EXHIBIT 1

                                                               SIGNATURE PAGE TO
                                                        THE ENDO PHARMACEUTICALS
                                                      CREDIT AGREEMENT AMENDMENT

To Approve the Amendment:

Name of Institution      WACHOVIA BANK, NATIONAL ASSOCIATION

                         by   /c/ James Travagline
                            ------------------------------
                             Name: James Travagline
                             Title: Vice President
<PAGE>
                                                               SIGNATURE PAGE TO
                                                        THE ENDO PHARMACEUTICALS
                                                      CREDIT AGREEMENT AMENDMENT

To Approve the Amendment:

Name of Institution      CITICORP NORTH AMERICA, INC.

                         by   /c/ F.R. Lowe
                            ----------------------
                             Name: F.R. Lowe
                             Title:  VP<PAGE>
                                                                   Exhibit 10.37
                       ENDO PHARMACEUTICALS HOLDINGS INC.
                            2004 STOCK INCENTIVE PLAN

1.    Establishment and Purpose.

      The purpose of the Endo Pharmaceuticals Holdings Inc. 2004 Stock Incentive
Plan (the "Plan") is to promote the interests of the Company and the
stockholders of the Company by providing directors, officers, employees and
consultants of the Company with appropriate incentives and rewards to encourage
them to enter into and continue in the employ or service of the Company, to
acquire a proprietary interest in the long-term success of the Company and to
reward the performance of individuals in fulfilling their personal
responsibilities for long-range achievements.

2.    Administration of the Plan.

      The Plan shall be administered by a Committee appointed by the Board of
Directors. The Committee shall have the authority, in its sole discretion,
subject to and not inconsistent with the express terms and provisions of the
Plan, to administer the Plan and to exercise all the powers and authorities
either specifically granted to it under the Plan or necessary or advisable in
the administration of the Plan, including, without limitation, the authority to
grant Awards; to determine the persons to whom and the time or times at which
Awards shall be granted; to determine the type and number of Awards to be
granted; to determine the number of shares of stock to which an Award may relate
and the terms, conditions, restrictions and performance criteria relating to any
Award; to determine whether, to what extent, and under what circumstances an
Award may be settled, cancelled, forfeited, exchanged or surrendered; to make
adjustments in the performance goals in recognition of unusual or nonrecurring
events affecting the Company or the financial statements of the Company (to the
extent not inconsistent with Section 162(m) of the Code, if applicable), or in
response to changes in applicable laws, regulations, or accounting principles;
to construe and interpret the Plan and any Award; to prescribe, amend and
rescind rules and regulations relating to the Plan; to determine the terms and
provisions of Agreements; and to make all other determinations deemed necessary
or advisable for the administration of the Plan.

      The Committee may, in its absolute discretion, without amendment to the
Plan, (a) accelerate the date on which any Option granted under the Plan becomes
exercisable, waive or amend the operation of Plan provisions respecting exercise
after termination of employment or otherwise adjust any of the terms of such
Option, and (b) accelerate the vesting date, or waive any condition imposed
hereunder, with respect to any share of Restricted Stock, or other Award or
otherwise adjust any of the terms applicable to any such Award. Notwithstanding
the foregoing, and subject to Sections 4(c) and 4(d), neither the Board of
Directors, the Committee nor their respective delegates shall have the authority
to reprice (or cancel and regrant) any Option or, if applicable, other Award at
a lower exercise, base or purchase price without first obtaining the approval of
the Company's stockholders.

<PAGE>

      Subject to Section 162(m) of the Code and except as required by Rule 16b-3
with respect to grants of Options to individuals who are subject to Section 16
of the Exchange Act, or as otherwise required for compliance with Rule 16b-3 or
other applicable law, the Committee may delegate all or any part of its
authority under the Plan to an employee, employees or committee of employees.

      Subject to Section 162(m) of the Code and Section 16 of the Exchange Act,
to the extent the Committee deems it necessary, appropriate or desirable to
comply with foreign law or practices and to further the purpose of the Plan, the
Committee may, without amending this Plan, establish special rules applicable to
Options granted to Participants who are foreign nationals, are employed outside
the United States, or both, including rules that differ from those set forth in
the Plan, and grant Options to such Participants in accordance with those rules.

3.    Definitions.

            (a)   "Agreement" shall mean the written agreement between the
Company and a Participant evidencing an Award.

            (b)   "Award" shall mean any Option, Restricted Stock, Stock Bonus
award, Stock Appreciation Right or Performance Award granted pursuant to the
terms of the Plan.

            (c)   "Board of Directors" shall mean the Board of Directors of the
Company.

            (d)   "Cause" shall mean a termination of a Participant's employment
by the Company or any of its Subsidiaries due to (i) the continued failure,
after written notice, by such Participant substantially to perform his or her
duties with the Company or any of its Subsidiaries (other than any such failure
resulting from incapacity due to reasonably documented physical illness or
injury or mental illness), (ii) the engagement by such Participant in serious
misconduct that causes, or in the good faith judgment of the Board of Directors
may cause, harm (financial or otherwise) to the Company or any of its
Subsidiaries including, without limitation, (A) the disclosure of material
secret or confidential information of the Company or any of its Subsidiaries (B)
the potential debarment of the Company or any of its Subsidiaries by the U.S.
Food and Drug Administration or any successor agency (the "FDA"), or (C) the
possibility that the registration of the Company or any of its Subsidiaries with
the U.S. Drug Enforcement Administration or any successor agency (the "DEA")
could be revoked or an application with the DEA could be denied, (iii) the
potential debarment of such Participant by the FDA, or (iv) the material breach
by the Participant of any agreement between such Participant, on the one hand,
and the Company or Kelso, on the other hand.

            (e)   A "Change in Control" shall be deemed to have occurred if the
event set forth in any one of the following paragraphs shall have occurred:

            (i)   any Person is or becomes the "Beneficial Owner" (as defined in
                  Rule 13d-3 under the Exchange Act), directly or indirectly, of
                  se-

                                        2
<PAGE>

                  curities of the Company (not including in the securities
                  Beneficially Owned by such Person any securities acquired
                  directly from the Company) representing 25% or more of the
                  Company's then outstanding securities, excluding any Person
                  who becomes such a Beneficial Owner in connection with a
                  transaction described in clause (A) of paragraph (iii) below;
                  or

            (ii)  the following individuals cease for any reason to constitute a
                  majority of the number of directors then serving: individuals
                  who, on the Effective Date, constitute the Board of Directors
                  and any new director (other than a director whose initial
                  assumption of office is in connection with an actual or
                  threatened election contest, including but not limited to a
                  consent solicitation, relating to the election of directors of
                  the Company) whose appointment or election by the Board of
                  Directors or nomination for election by the Company's
                  stockholders was approved or recommended by a vote of at least
                  a two-thirds of the directors then still in office who either
                  were directors on the Effective Date or whose appointment,
                  election or nomination for election was previously so approved
                  or recommended; or

            (iii) there is consummated a merger or consolidation of the Company
                  with any other corporation other than (A) a merger or
                  consolidation which would result in the voting securities of
                  the Company outstanding immediately prior to such merger or
                  consolidation continuing to represent (either by remaining
                  outstanding or by being converted into voting securities of
                  the surviving entity or any parent thereof) at least 50% of
                  the combined voting power of the voting securities of the
                  Company or such surviving entity or any parent thereof
                  outstanding immediately after such merger or consolidation, or
                  (B) a merger or consolidation effected to implement a
                  re-capitalization of the Company (or similar transaction) in
                  which no Person is or becomes the Beneficial Owner, directly
                  or indirectly, of securities of the Company (not including in
                  the securities Beneficially Owned by such Person any
                  securities acquired directly from the Company) representing
                  25% or more of the combined voting power of the Company's then
                  outstanding securities; or

            (iv)  the stockholders of the Company approve a plan of complete
                  liquidation or dissolution of the Company or there is
                  consummated an agreement for the sale or disposition by the
                  Company of all or substantially all of the Company's assets,
                  other than a sale or disposition by the Company of all or
                  substantially all of the Company's assets to an entity at
                  least 75% of the combined voting power of the voting
                  securities of which are owned by Persons in substantially the
                  same proportions as their ownership of the Company

                                        3
<PAGE>

                  immediately prior to such sale.

            Notwithstanding the foregoing, a Change in Control shall not result
from the transfer of the Company's then outstanding securities to current
members or future direct or indirect members of Endo Pharma LLC.

            (f)   "Code" shall mean the Internal Revenue Code of 1986, as
amended from time to time, and any regulations promulgated thereunder.

            (g)   "Committee" shall mean, at the discretion of the Board of
Directors, a Committee of the Board of Directors, which shall consist of two or
more persons, each of whom, unless otherwise determined by the Board of
Directors, is an "outside director" within the meaning of Section 162(m) of the
Code and a "nonemployee director" within the meaning of Rule 16b-3.

            (h)   "Company" shall mean Endo Pharmaceuticals Holdings Inc., a
Delaware corporation, and, where appropriate, each of its Subsidiaries.

            (i)   "Company Stock" shall mean the common stock of the Company,
par value $.01 per share.

            (j)   "Disability" shall mean permanent disability as determined
pursuant to the Company's long-term disability plan or policy, in effect at the
time of such Disability.

            (k)   "Effective Date" shall mean the date as of which this Plan is
adopted by the Board of Directors.

            (l)   "Exchange Act" shall mean the Securities Exchange Act of 1934,
as amended from time to time.

            (m)   The "Fair Market Value" of a share of Company Stock, as of a
date of determination, shall mean (1) the closing sales price per share of
Company Stock on the national securities exchange on which such stock is
principally traded on the date of the grant of such Award, or (2) if the shares
of Company Stock are not listed or admitted to trading on any such exchange, the
closing price as reported by the Nasdaq Stock Market for the last preceding date
on which there was a sale of such stock on such exchange, or (3) if the shares
of Company Stock are not then listed on a national securities exchange or traded
in an over-the-counter market or the value of such shares is not otherwise
determinable, such value as determined by the Committee in good faith upon the
advice of a qualified valuation expert. In no event shall the fair market value
of any share of Company Stock, the Option exercise price of any Option, the
appreciation base per share of Company Stock under any Stock Appreciation Right,
or the amount payable per share of Company Stock under any other Award, be less
than the par value per share of Company Stock.

            (n)   "Kelso" shall mean Kelso Investment Associates V, L.P., a
Delaware limited partnership together with Kelso Equity Partners V, L.P., a
Delaware limited

                                        4
<PAGE>

partnership.

            (o)   "Incentive Stock Option" shall mean an Option that is an
"incentive stock option" within the meaning of Section 422 of the Code, or any
successor provision, and that is designated by the Committee as an Incentive
Stock Option.

            (p)   "Nonemployee Director" shall mean a member of the Board of
Directors who is not an employee of the Company.

            (q)   "Nonqualified Stock Option" shall mean an Option other than an
Incentive Stock Option.

            (r)   "Option" shall mean an option to purchase shares of Company
Stock granted pursuant to Section 6(b).

            (s)   "Participant" shall mean an employee, consultant or director
of the Company to whom an Award is granted pursuant to the Plan, and, upon the
death of the employee, consultant or director, his or her successors, heirs,
executors and administrators, as the case may be.

            (t)   "Performance Award" shall mean an Award granted to a
Participant pursuant to Section 6(f) hereof.

            (u)   "Person" shall have the meaning set forth in Section 3(a)(9)
of the Exchange Act, except that such term shall not include (1) the Company,
(2) a trustee or other fiduciary holding securities under an employee benefit
plan of the Company, (3) an underwriter temporarily holding securities pursuant
to an offering of such securities, or (4) a corporation owned, directly or
indirectly, by the stockholders of the Company in substantially the same
proportions as their ownership of stock of the Company.

            (v)   "Restricted Stock" shall mean a share of Company Stock which
is granted pursuant to the terms of Section 6(e) hereof.

            (w)   "Rule 16b-3" shall mean the Rule 16b-3 promulgated under the
Exchange Act, as amended from time to time.

            (x)   "Securities Act" shall mean the Securities Act of 1933, as
amended from time to time.

            (y)   "Stock Appreciation Right" shall mean the right, granted to a
Participant under Section 6(d), to be paid an amount measured by the
appreciation in the Fair Market Value of a share of Company Stock from the date
of grant to the date of exercise of the right, with payment to be made in cash
and/or a share of Company Stock, as specified in the Award or determined by the
Committee.

            (z)   "Stock Bonus" shall mean a bonus payable in shares of Company
Stock granted pursuant to Section 6(e) hereof.

                                        5
<PAGE>

            (aa)  "Subsidiary" shall mean a "subsidiary corporation" within the
meaning of Section 424(f) of the Code.

4.    Stock Subject to the Plan.

            (a)   Shares Available for Awards.

      The maximum number of shares of Company Stock reserved for issuance under
the Plan shall be 4,000,000 shares (subject to adjustment as provided herein).
Such shares may be authorized but unissued Company Stock or authorized and
issued Company Stock held in the Company's treasury. The Committee may direct
that any stock certificate evidencing shares issued pursuant to the Plan shall
bear a legend setting forth such restrictions on transferability as may apply to
such shares pursuant to the Plan.

            (b)   Individual Limitation.

      To the extent required by Section 162(m) of the Code, the total number of
shares of Company Stock subject to Awards awarded to any Participant during any
tax year of the Company, shall not exceed 750,000 shares (subject to adjustment
as provided herein).

            (c)   Adjustment for Change in Capitalization.

      In the event that the Committee shall determine that any dividend or other
distribution (whether in the form of cash, Company Stock, or other property),
re-capitalization, Company Stock split, reverse Company Stock split,
reorganization, merger, consolidation, spin-off, combination, repurchase, or
share exchange, or other similar corporate transaction or event, makes an
adjustment appropriate in order to prevent dilution or enlargement of the rights
of Participants under the Plan, then the Committee shall make such equitable
changes or adjustments as it deems necessary or appropriate to any or all of (1)
the number and kind of shares of Company Stock which may thereafter be issued in
connection with Awards, (2) the number and kind of shares of Company Stock
issued or issuable in respect of outstanding Awards, (3) the exercise price,
grant price or purchase price relating to any Award, and (4) the maximum number
of shares subject to Awards which may be awarded to any employee during any tax
year of the Company; provided that, with respect to Incentive Stock Options, any
such adjustment shall be made in accordance with Section 424 of the Code.

            (d)   Adjustment for Change or Exchange of Shares for Other
Consideration.

      In the event the outstanding shares of Company Stock shall be changed into
or exchanged for any other class or series of capital stock or cash, securities
or other property pursuant to a re-capitalization, reclassification, merger,
consolidation, combination or similar transaction ("Transaction"), then, unless
otherwise determined by the Committee, (1) each Option shall thereafter become
exercisable (in accordance with the applicable vesting schedule) for the number
and/or kind of capital stock, and/or the amount of cash, securities or other
property so distributed, into which the shares of Company Stock subject to the
Option would have been changed or exchanged had the

                                        6
<PAGE>

Option been exercised in full prior to such transaction, provided that, if the
kind or amount of capital stock or cash, securities or other property received
in such transaction is not the same for each outstanding share, then the kind or
amount of capital stock or cash, securities or other property for which the
Option shall thereafter become exercisable shall be the kind and amount so
receivable per share by a plurality of the shares of Company Stock, and provided
further that, if necessary, the provisions of the Option shall be appropriately
adjusted so as to be applicable, as nearly as may reasonably be, to any shares
of capital stock, cash, securities or other property thereafter issuable or
deliverable upon exercise of the Option, and (2) each Award that is not an
Option and that is not automatically changed in connection with the Transaction
shall represent an Award with respect to the number and/or kind of shares of
capital stock, and/or the amount of cash, securities or other property so
distributed, into which the number of shares of Company Stock covered by the
Award would have been changed or exchanged had they been held by a stockholder.

            (e)   Reuse of Shares.

      If any shares subject to an Award are forfeited, cancelled, exchanged or
surrendered or if an Award terminates or expires without a distribution of
shares to the Participant, or if shares of stock are surrendered or withheld as
payment of either the exercise price of an Award and/or withholding taxes in
respect of an Award, the shares of stock with respect to such Award shall, to
the extent of any such forfeiture, cancellation, exchange, surrender,
withholding, termination or expiration, again be available for Awards under the
Plan. Notwithstanding the foregoing, upon the exercise of any Award granted in
tandem with any other Awards, such related Awards shall be cancelled to the
extent of the number of shares of Company Stock as to which the Award is
exercised and such number of shares shall no longer be available for Awards
under the Plan.

5.    Eligibility.

      The persons who shall be eligible to receive Awards pursuant to the Plan
shall be such employees (including officers of the Company and its Subsidiary,
whether or not they are directors of the Company or its Subsidiary), Nonemployee
Directors, and consultants of the Company and its Subsidiaries as the Committee
shall select from time to time.

6.    Awards Under the Plan.

            (a)   Agreement.

      The Committee may grant Awards in such amounts and with such terms and
conditions as the Committee shall determine, subject to the terms and provisions
of the Plan. Each Award granted under the Plan (except an unconditional Stock
Bonus) shall be evidenced by an Agreement as the Committee may in its sole
discretion deem necessary or desirable and unless the Committee determines
otherwise, such Agreement must be signed, acknowledged and returned by the
Participant to the Company. Unless the Committee determines otherwise, any
failure by the Participant to sign and return the Agree-

                                        7
<PAGE>

ment shall cause such Award to the Participant to be null and void. By accepting
an Award or other benefits under the Plan (including participation in the Plan),
each Participant, shall be conclusively deemed to have indicated acceptance and
ratification of, and consent to, all provisions of the Plan and the Agreement.

            (b)   Stock Options.

                  (1)   Grant of Stock Options. The Committee may grant Options
      under the Plan to purchase shares of Company Stock in such amounts and
      subject to such terms and conditions as the Committee shall from time to
      time determine in its sole discretion, subject to the terms and provisions
      of the Plan. Unless otherwise determined by the Committee, the exercise
      price of the share purchasable under an Option shall be the Fair Market
      Value per share on the grant date of such Option.

                  (2)   Each Option shall be clearly identified in the
      applicable Agreement as either an Incentive Stock Option or a Nonqualified
      Stock Option.

            (c)   Special Requirements for Incentive Stock Options.

                  (1)   To the extent that the aggregate Fair Market Value of
      shares of Company Stock with respect to which Incentive Stock Options are
      exercisable for the first time by a Participant during any calendar year
      under the Plan and any other stock option plan of the Company shall exceed
      $100,000, such Options shall be treated as Nonqualified Stock Options.
      Such Fair Market Value shall be determined as of the date on which each
      such Incentive Stock Option is granted.

                  (2)   No Incentive Stock Option may be granted to an
      individual if, at the time of the proposed grant, such individual owns (or
      is deemed to own under the Code) stock possessing more than ten percent of
      the total combined voting power of all classes of stock of the Company
      unless (A) the exercise price of such Incentive Stock Option is at least
      110 percent of the Fair Market Value of a share of Company Stock at the
      time such Incentive Stock Option is granted and (B) such Incentive Stock
      Option is not exercisable after the expiration of five years from the date
      such Incentive Stock Option is granted.

            (d)   Stock Appreciation Rights.

                  (1)   The Committee may grant a related Stock Appreciation
      Right in connection with all or any part of an Option granted under the
      Plan, either at the time such Option is granted or at any time thereafter
      prior to the exercise, termination or cancellation of such Option, and
      subject to such terms and conditions as the Committee shall from time to
      time determine in its sole discretion, consistent with the terms and
      provisions of the Plan. The holder of a related Stock Appreciation Right
      shall, subject to the terms and conditions of the Plan and the applicable
      Agreement, have the right by exercise thereof to surrender to the Company
      for cancellation all or a portion of such related Stock

                                        8
<PAGE>

      Appreciation Right, but only to the extent that the related Option is then
      exercisable, and to be paid therefor an amount equal to the excess (if
      any) of (i) the aggregate Fair Market Value of the shares of Company Stock
      subject to the related Stock Appreciation Right or portion thereof
      surrendered (determined as of the exercise date), over (ii) the aggregate
      appreciation base of the shares of Company Stock subject to the Stock
      Appreciation Right or portion thereof surrendered. Upon any exercise of a
      related Stock Appreciation Right or any portion thereof, the number of
      shares of Company Stock subject to the related Option shall be reduced by
      the number of shares of Company Stock in respect of which such Stock
      Appreciation Right shall have been exercised.

                  (2)   The Committee may grant unrelated Stock Appreciation
      Rights in such amount and subject to such terms and conditions, as the
      Committee shall from time to time determine in its sole discretion,
      subject to the terms and provisions of the Plan. The holder of an
      unrelated Stock Appreciation Right shall, subject to the terms and
      conditions of the Plan and the applicable Agreement, have the right to
      surrender to the Company for cancellation all or a portion of such Stock
      Appreciation Right, but only to the extent that such Stock Appreciation
      Right is then exercisable, and to be paid therefor an amount equal to the
      excess (if any) of (i) the aggregate Fair Market Value of the shares of
      Company Stock subject to the Stock Appreciation Right or portion thereof
      surrendered (determined as of the exercise date), over (ii) the aggregate
      appreciation base of the shares of Company Stock subject to the Stock
      Appreciation Right or portion thereof surrendered.

                  (3)   The grant or exercisability of any Stock Appreciation
      Right shall be subject to such conditions as the Committee, in its sole
      discretion, shall determine.

            (e)   Restricted Stock and Stock Bonus.

                  (1)   The Committee may grant Restricted Stock awards, alone
      or in tandem with other Awards under the Plan, subject to such
      restrictions, terms and conditions, as the Committee shall determine in
      its sole discretion and as shall be evidenced by the applicable
      Agreements. The vesting of a Restricted Stock award granted under the Plan
      may be conditioned upon the completion of a specified period of employment
      or service with the Company or any Subsidiary, upon the attainment of
      specified performance goals, and/or upon such other criteria as the
      Committee may determine in its sole discretion.

                  (2)   Each Agreement with respect to a Restricted Stock award
      shall set forth the amount (if any) to be paid by the Participant with
      respect to such Award and when and under what in circumstances such
      payment is required to be made.

                  (3)   The Committee may, upon such terms and conditions as the
      Committee determines, provide that a certificate or certificates
      representing the

                                        9
<PAGE>

      shares underlying a Restricted Stock award shall be registered in the
      Participant's name and bear an appropriate legend specifying that such
      shares are not transferable and are subject to the provisions of the Plan
      and the restrictions, terms and conditions set forth in the applicable
      Agreement, or that such certificate or certificates shall be held in
      escrow by the Company on behalf of the Participant until such shares
      become vested or are forfeited. Except as provided in the applicable
      Agreement, no shares underlying a Restricted Stock award may be assigned,
      transferred, or otherwise encumbered or disposed of by the Participant
      until such shares have vested in accordance with the terms of such Award.

                  (4)   If and to the extent that the applicable Agreement may
      so provide, a Participant shall have the right to vote and receive
      dividends on the shares underlying a Restricted Stock award granted under
      the Plan. Unless otherwise provided in the applicable Agreement, any stock
      received as a dividend on or in connection with a stock split of the
      shares underlying a Restricted Stock award shall be subject to the same
      restrictions as the shares underlying such Restricted Stock award.

                  (5)   The Committee may grant Stock Bonus awards, alone or in
      tandem with other Awards under the Plan, subject to such terms and
      conditions as the Committee shall determine in its sole discretion and as
      may be evidenced by the applicable Agreement.

            (f)   Performance Awards.

                  (1)   The Committee may grant Performance Awards, alone or in
      tandem with other Awards under the Plan, to acquire shares of Company
      Stock in such amounts and subject to such terms and conditions as the
      Committee shall from time to time in its sole discretion determine,
      subject to the terms of the Plan.

                  (2)   In the event that the Committee grants a Performance
      Award (other than Nonqualified Stock Option or Incentive Stock Option),
      that is intended to constitute qualified performance-based compensation
      within the meaning Section 162(m) of the Code, the following rules shall
      apply (as such rules may be modified by the Committee to conform with Code
      section 162(m) and the Treasury Regulations thereunder as may be in effect
      from time to time, and any amendments, revisions or successor provisions
      thereto): (a) payments under the Performance Award shall be made solely on
      account of the attainment of one or more objective performance goals
      established in writing by the Committee not later than 90 days after the
      commencement of the period of service to which the Performance Award
      relates (or if less, one-third of such period of service); (b) the
      performance goal(s) to which the Performance Award relates shall be based
      on one or more of the following business criteria applied to the
      Participant and/or a business unit or the Company and/or a Subsidiary: (1)
      return on total stockholder equity; (2) earnings per share of Company
      Stock; (3) net income (before or after taxes); (4) earnings before all or
      any interest, taxes, depreciation and/or amortization ("EBIT", "EBITA" or
      "EBITDA"); (5) inventory

                                       10
<PAGE>

      goals; (6) return on assets; (7) market share; (8) cost reduction goals;
      (9) earnings from continuing operations; levels of expense, cost or
      liability; (10) any combination of, or a specified increase or decrease of
      one or more of the foregoing over a specified period; and (11) such other
      criteria as the stockholders of the Company may approve; in each case, as
      determined in accordance with generally accepted accounting principles;
      and (c) once granted, the Committee may not have discretion to increase
      the amount payable under such stock award, provided, however, that whether
      or not a Performance Award is intended to constitute qualified
      performance-based compensation within the meaning of Section 162(m) of the
      Code, the Committee shall have the authority to make appropriate
      adjustments in performance goals under an Award to reflect the impact of
      extraordinary items not reflected in such goals. For purposes of the Plan,
      extraordinary items shall be defined as (1) any profit or loss
      attributable to acquisitions or dispositions of stock or assets, (2) any
      changes in accounting standards that may be required or permitted by the
      Financial Accounting Standards Board or adopted by the Company after the
      goal is established, (3) all items of gain, loss or expense for the year
      related to restructuring charges for the Company, (4) all items of gain,
      loss or expense for the year determined to be extraordinary or unusual in
      nature or infrequent in occurrence or related to the disposal of a segment
      of a business, (5) all items of gain, loss or expense for the year related
      to discontinued operations that do not qualify as a segment of a business
      as defined in APB Opinion No. 30, and (6) such other items as may be
      prescribed by Section 162(m) of the Code and the Treasury Regulations
      thereunder as may be in effect from time to time, and any amendments,
      revisions or successor provisions and any changes thereto. The Committee
      shall, prior to making payment under any award under this Section 6(f),
      certify in writing that all applicable performance goals have been
      attained.

            (g)   Exercisability of Awards; Cancellation of Awards in Certain
                  Cases.

                  (1)   Each Agreement with respect to an Option or Stock
      Appreciation Right shall set forth the period during which and the
      conditions subject to which the Option or Stock Appreciation Right
      evidenced thereby shall be exercisable, and each Agreement with respect to
      a Restricted Stock award or Performance Award shall set forth the period
      after which and the conditions subject to which the shares underlying such
      Award shall vest or be deliverable, all such periods and conditions to be
      determined by the Committee in its sole discretion.

                  (2)   No Option or Stock Appreciation Right may be exercised
      and no shares of Company Stock underlying any other Award under the Plan
      may vest or become deliverable more than ten (10) years after the date of
      grant (the "Stated Expiration Date").

                  (3)   An Option or Stock Appreciation Right shall be
      exercisable by the filing of a written notice of exercise or a notice of
      exercise in such other manner with the Company, on such form and in such
      manner as the Committee

                                       11
<PAGE>

      shall in its sole discretion prescribe, and by payment in accordance with
      Section 6(h) hereof.

                  (4)   Unless the applicable Agreement provides otherwise, in
      the case of an Option or Stock Appreciation Right, at any time after the
      Company's receipt of written notice of exercise of an Option or Stock
      Appreciation Right and prior to the Option or Stock Appreciation Right
      exercise date (as defined in subsection 5), and in the case of a stock
      award or Performance Award, at any time within the six (6) business days
      immediately preceding the otherwise applicable date on which the
      previously Restricted Stock, stock award or Performance Award would
      otherwise have become unconditionally vested or the shares subject thereto
      unconditionally deliverable, the Committee, in its sole discretion, shall
      have the right, by written notice to the Participant, to cancel such Award
      or any part thereof if the Committee, in its sole judgment, determines
      that legal or contractual restrictions and/or blockage and/or other market
      considerations would make the Company's acquisition of Company Stock from,
      and/or the Participant's sale of Company Stock to, the public markets
      illegal, impracticable or inadvisable. If the Committee determines to
      cancel all or any part of an Award, the Company shall pay to the
      Participant an amount equal to the excess of (i) the aggregate Fair Market
      Value of the shares of Company Stock subject to the Award or part thereof
      canceled (determined as of the Option or Stock Appreciation Right exercise
      date, or the date that shares would have been unconditionally vested or
      delivered in the case of Restricted Stock, Stock Bonus or Performance
      Award), over (ii) the aggregate Option exercise price or appreciation base
      of the Stock Appreciation Right or part thereof canceled (in the case of
      an Option or Stock Appreciation Right) or any amount payable as a
      condition of delivery of shares (in the case of Restricted Stock, Stock
      Bonus or Performance Award). Such amount shall be delivered to the
      Participant as soon as practicable after such Award or part thereof is
      canceled.

                  (5)   Unless the applicable Agreement provides otherwise, the
      "Option exercise date" and the "Stock Appreciation Right exercise date"
      shall be the date that the written notice of exercise, together with
      payment, are received by the Company.

            (h)   Payment of Award Price.

                  (1)   Unless the applicable Agreement provides otherwise or
      the Committee in its sole discretion otherwise determines, any written
      notice of exercise of an Option or Stock Appreciation Right must be
      accompanied by payment of the full Option or Stock Appreciation Right
      exercise price. If Section 6(g)(4) applies, and the six (6) business day
      delay for the Option exercise date or Stock Appreciation Right exercise
      date is applied, the Participant shall have no right to pay the Option or
      Stock Appreciation Right exercise price or to receive Company Stock with
      respect to the Option or Stock Appreciation Right exercise prior to the
      lapse of such six (6) business days.

                                       12
<PAGE>

                  (2)   Payment of the Option exercise price and of any other
      payment required by the Agreement to be made pursuant to any other Award
      shall be made in any combination of the following: (a) by certified or
      official bank check payable to the Company (or the equivalent thereof
      acceptable to the Committee) and/or (b) with the consent of the Committee
      in its sole discretion, by personal check (subject to collection) which
      may in the Committee's discretion be deemed conditional; Payment in
      accordance with clause (a) of this Section 6(h)(2) may be deemed to be
      satisfied, if and to the extent that the applicable Agreement so provides
      or the Committee permits, by delivery to the Company of an assignment of a
      sufficient amount of the proceeds from the sale of Company Stock to be
      acquired pursuant to the Award to pay for all of the Company Stock to be
      acquired pursuant to the Award and an authorization to the broker or
      selling agent to pay that amount to the Company and to effect such sale at
      the time of exercise or other delivery of shares of Company Stock;
      provided that any such sale of Company Stock shall not occur prior to the
      six-month anniversary of the acquisition thereof.

7.    Termination of Employment.

            (a)   Unless the applicable Agreement provides otherwise or the
Committee in its sole discretion determines otherwise, upon termination of a
Participant's employment or service with the Company and its Subsidiaries by the
Company or its Subsidiary for Cause (or in the case of a Nonemployee Director
upon such Nonemployee Director's failure to be renominated as Nonemployee
Director of the Company), the portions of outstanding Options and Stock
Appreciation Rights granted to such Participant that are exercisable as of the
date of such termination of employment or service shall remain exercisable, and
any payment or notice provided for under the terms of any other outstanding
Award as respects the portion thereof that is vested as of the date of such
termination of employment or service, may be given, for a period of thirty (30)
days from and including the date of termination of employment or service (and
shall thereafter terminate). All portions of outstanding Options or Stock
Appreciation Rights granted to such Participant which are not exercisable as of
the date of such termination of employment or service, and any other outstanding
Award which is not vested as of the date of such termination of employment or
service shall terminate upon the date of such termination of employment or
service.

            (b)   Unless the applicable Agreement provides otherwise or the
Committee in its sole discretion determines otherwise, upon termination of the
Participant's employment or service with the Company and its Subsidiaries for
any reason other than as described in subsection (a), (c), (d) or (e) hereof,
the portions of outstanding Options and Stock Appreciation Rights granted to
such Participant that are exercisable as of the date of such termination of
employment or service shall remain exercisable for a period of ninety (90) days
(and shall terminate thereafter), and any payment or notice provided for under
the terms of any other outstanding Award as respects the portion thereof vested
as of the date of termination of employment or service may be given, for a
period of ninety (90) days from and including the date of termination of
employment or service (and shall terminate thereafter). All additional portions
of outstanding Options or

                                       13
<PAGE>

Stock Appreciation Rights granted to such Participant which are not exercisable
as of the date of such termination of employment or service, and any other
outstanding Award which is not vested as of the date of such termination of
employment or service shall terminate upon the date of such termination of
employment or service.

            (c)   Unless the applicable Agreement provides otherwise or the
Committee in its sole discretion determines otherwise, if the Participant
voluntarily retires with the consent of the Company or the Participant's
employment or service terminates due to Disability, all outstanding Options,
Stock Appreciation Rights and all other outstanding Awards granted to such
Participant shall continue to vest in accordance with the terms of the
applicable Agreements. The Participant shall be entitled to exercise each such
Option or Stock Appreciation Right and to make any payment, give any notice or
to satisfy other condition under each such other Award, in each case, for a
period of one (1) year from and including the later of (i) date such entire
Award becomes vested or exercisable in accordance with the terms of such Award
and (ii) the date of termination of employment or retirement, and thereafter
such Awards or parts thereof shall be canceled. Notwithstanding the foregoing,
the Committee may in its sole discretion provide for a longer or shorter period
for exercise of an Option or Stock Appreciation Right or may permit a
Participant to continue vesting under an Option, Stock Appreciation Right or
Restricted Stock award or to make any payment, give any notice or to satisfy
other condition under any other Award. The Committee may in its sole discretion
determine (i) whether any termination of employment or service is a voluntary
retirement with the Company's consent or is due to Disability for purposes of
the Plan, (ii) whether any leave of absence (including any short-term or
long-term Disability or medical leave) constitutes a termination of employment
or service within the meaning of the Plan, (iii) the applicable date of any such
termination of employment or service, and (iv) the impact, if any, of any of the
foregoing on Awards under the Plan.

            (d)   Unless the applicable Agreement provides otherwise or the
Committee in its sole discretion determines otherwise, if the Participant's
employment or service terminates by reason of death, or if the Participant's
employment or service terminates under circumstances providing for continued
rights under subsection (b), (c), or (e) of this Section 7 and during the period
of continued rights described in subsection (b), (c) or (e) the Participant
dies, all outstanding Options, Restricted Stock and Stock Appreciation Rights
granted to such Participant shall become fully exercisable, and any payment or
notice provided for under the terms of any other outstanding Award may be
immediately paid or given and any condition may be satisfied, by the person to
whom such rights have passed under the Participant's will (or if applicable,
pursuant to the laws of descent and distribution) for a period of one (1) year
from and including the date of the Participant's death and thereafter all such
Awards or parts thereof shall be canceled.

            (e)   Unless the applicable Agreement provides otherwise or the
Committee in its sole discretion determines otherwise, upon termination of a
Participant's employment or service with the Company and its Subsidiaries (i) by
the Company or its Subsidiaries without Cause (including, in case of a
Nonemployee Director, the failure to be elected as a Nonemployee Director) or
(ii) by the Participant for "good reason" or any like term as defined under any
employment agreement with the Company or a Subsidiary

                                       14
<PAGE>

to which a Participant may be a party to, the portions of outstanding Options
and Stock Appreciation Rights granted to such Participant which are exercisable
as of the date of termination of employment or service of such Participant shall
remain exercisable, and any payment or notice provided for under the terms of
any other outstanding Award as respects the portion thereof vested as of the
date of termination of employment or service may be given, for a period of one
(1) year from and including the date of termination of employment or service and
shall terminate thereafter. Any other outstanding Award shall terminate as of
the date of such termination of employment or service.

            (f)   Notwithstanding anything in this Section 7 to the contrary, no
Option or Stock Appreciation Right may be exercised and no shares of Company
Stock underlying any other Award under the Plan may vest or become deliverable
past the Stated Expiration Date.

8.    Effect of Change in Control.

      Unless the applicable Agreement provides otherwise or the Committee in its
sole discretion determines otherwise, in the event of a Change of Control:

            (a)   any Award carrying a right to exercise that was not previously
exercisable and vested shall become fully exercisable and vested; and

            (b)   the restrictions, deferral limitations, payment conditions,
and forfeiture conditions applicable to any other Award granted under the Plan
shall lapse and such Awards shall be deemed fully vested, and any performance
goals imposed with respect to Awards shall be deemed to be fully achieved.

9.    Miscellaneous.

            (a)   Notwithstanding any other provision hereof, the Committee
shall have the right at any time to deny or delay a Participant's exercise of
Options, if such Participant is reasonably believed by the Committee (i) to be
engaged in material conduct adversely affecting the Company or (ii) to be
contemplating such conduct, unless and until the Committee shall have received
reasonable assurance that the Participant is not engaged in, and is not
contemplating, such material conduct adverse to the interests of the Company.

            (b)   Participants are and at all times shall remain subject to the
trading window policies adopted by the Company from time to time throughout the
period of time during which they may exercise Options, Stock Appreciation Rights
or sell shares of Company Stock acquired pursuant to the Plan.

10.   No Special Employment Rights; No Right to Award.

      (a)   Nothing contained in the Plan or any Agreement shall confer upon any
Participant any right with respect to the continuation of employment or service
by the Company or interfere in any way with the right of the Company, subject to
the terms of any separate employment agreement to the contrary, at any time to
terminate such em-

                                       15
<PAGE>

ployment or service or to increase or decrease the compensation of the
Participant.

            (b)   No person shall have any claim or right to receive an Award
hereunder. The Committee's granting of an Award to a Participant at any time
shall neither require the Committee to grant any other Award to such Participant
or other person at any time or preclude the Committee from making subsequent
grants to such Participant or any other person.

11.   Securities Matters.

            (a)   The Company shall be under no obligation to effect the
registration pursuant to the Securities Act of any interests in the Plan or any
shares of Company Stock to be issued hereunder or to effect similar compliance
under any state laws. Notwithstanding anything herein to the contrary, the
Company shall not be obligated to cause to be issued or delivered any
certificates evidencing shares of Company Stock pursuant to the Plan unless and
until the Company is advised by its counsel that the issuance and delivery of
such certificates is in compliance with all applicable laws, regulations of
governmental authority and the requirements of any securities exchange on which
shares of Company Stock are traded. The Committee may require, as a condition of
the issuance and delivery of certificates evidencing shares of Company Stock
pursuant to the terms hereof, that the recipient of such shares make such
agreements and representations, and that such certificates bear such legends, as
the Committee, in its sole discretion, deems necessary or desirable.

            (b)   The transfer of any shares of Company Stock hereunder shall be
effective only at such time as counsel to the Company shall have determined that
the issuance and delivery of such shares is in compliance with all applicable
laws, regulations of governmental authority and the requirements of any
securities exchange on which shares of Company Stock are traded. The Committee
may, in its sole discretion, defer the effectiveness of any transfer of shares
of Company Stock hereunder in order to allow the issuance of such shares to be
made pursuant to registration or an exemption from registration or other methods
for compliance available under federal or state securities laws. The Committee
shall inform the Participant in writing of its decision to defer the
effectiveness of a transfer. During the period of such deferral in connection
with the exercise of an Award, the Participant may, by written notice, withdraw
such exercise and obtain the refund of any amount paid with respect thereto.

12.   Withholding Taxes.

            (a)   Whenever cash is to be paid pursuant to an Award, the Company
shall have the right to deduct therefrom an amount sufficient to satisfy any
federal, state and local withholding tax requirements related thereto.

            (b)   Whenever shares of Company Stock are to be delivered pursuant
to an Award, the Company shall have the right to require the Participant to
remit to the Company in cash an amount sufficient to satisfy any federal, state
and local withholding tax requirements related thereto. With the approval of the
Committee, a Participant may

                                       16
<PAGE>

satisfy the foregoing requirement by electing to have the Company withhold from
delivery shares of Company Stock having a value equal to the minimum amount of
tax required to be withheld. Such shares shall be valued at their Fair Market
Value on the date of which the amount of tax to be withheld is determined.
Fractional share amounts shall be settled in cash. Such a withholding election
may be made with respect to all or any portion of the shares to be delivered
pursuant to an Award.

13.   Notification of Election Under Section 83(b) of the Code.

      If any Participant shall, in connection with the acquisition of shares of
Company Stock under the Plan, make the election permitted under Section 83(b) of
the Code, such Participant shall notify the Company of such election within 10
days of filing notice of the election with the Internal Revenue Service.

14.   Non-Competition and Confidentiality.

      By accepting Awards and as a condition to the exercise of Awards and the
enjoyment of any benefits of the Plan, including participation therein, each
Participant agrees to be bound by and subject to non-competition,
confidentiality and invention ownership agreements acceptable to the Committee
or any officer or director to whom the Committee elects to delegate such
authority.

15.   Notification Upon Disqualifying Disposition Under Section 421(b) of the
      Code.

      Each Agreement with respect to an Incentive Stock Option shall require the
Participant to notify the Company of any disposition of shares of Company Stock
issued pursuant to the exercise of such Option under the circumstances described
in Section 421(b) of the Code (relating to certain disqualifying dispositions),
within 10 days of such disposition.

16.   Amendment or Termination of the Plan.

      The Board of Directors or the Committee may, at any time, suspend or
terminate the Plan or revise or amend it in any respect whatsoever; provided,
however, that the requisite stockholder approval shall be required if and to the
extent the Board of Directors or Committee determines that such approval is
appropriate or necessary for purposes of satisfying Sections 162(m) or 422 of
the Code or Rule 16b-3 or other applicable law. Awards may be granted under the
Plan prior to the receipt of such stockholder approval of the Plan but each such
grant shall be subject in its entirety to such approval and no Award may be
exercised, vested or otherwise satisfied prior to the receipt of such approval.
No amendment or termination of the Plan may, without the consent of a
Participant, adversely affect the Participant's rights under any outstanding
Award.

17.   Transfers Upon Death; Nonassignability.

            (a)   Upon the death of a Participant, outstanding Awards granted to
such Participant may be exercised only by the executor or administrator of the
Participant's estate or by a person who shall have acquired the right to such
exercise by

                                       17
<PAGE>

will or by the laws of descent and distribution. No transfer of an Award by will
or the laws of descent and distribution shall be effective to bind the Company
unless the Committee shall have been furnished with written notice thereof and
with a copy of the will and/or such evidence as the Committee may deem necessary
to establish the validity of the transfer and an agreement by the transferee to
comply with all the terms and conditions of the Award that are or would have
been applicable to the Participant and to be bound by the acknowledgments made
by the Participant in connection with the grant of the Award.

            (b)   During a Participant's lifetime, the Committee may, in its
discretion, pursuant to the provisions set forth in this clause (b), permit the
transfer, assignment or other encumbrance of an outstanding Option unless such
Option is an Incentive Stock Option and the Committee and the Participant
intends that it shall retain such status. Subject to the approval of the
Committee and to any conditions that the Committee may prescribe, a Participant
may, upon providing written notice to the General Counsel of the Company, elect
to transfer any or all Options granted to such Participant pursuant to the Plan
to members of his or her immediate family, including, but not limited to,
children, grandchildren and spouse or to trusts for the benefit of such
immediate family members or to partnerships in which such family members are the
only partners; provided, however, that no such transfer by any Participant may
be made in exchange for consideration. Any such transferee must agree, in
writing, to be bound by all provisions of the Plan.

18.   Effective Date and Term of Plan.

      The Plan shall become effective on the Effective Date, but the Plan (and
any grants of Awards made prior to stockholder approval of the Plan) shall be
subject to the requisite approval of the stockholders of the Company. In the
absence of such approval, such Awards shall be null and void. Unless earlier
terminated by the Board of Directors, the right to grant Awards under the Plan
shall terminate on the tenth anniversary of the Effective Date. Awards
outstanding at Plan termination shall remain in effect according to their terms
and the provisions of the Plan.

19.   Applicable Law.

      Except to the extent preempted by any applicable federal law, the Plan
shall be construed and administered in accordance with the laws of the State of
Delaware, without reference to its principles of conflicts of law.

20.   Participant Rights.

            (a)   No Participant shall have any claim to be granted any award
under the Plan, and there is no obligation for uniformity of treatment for
Participants. Except as provided specifically herein, a Participant or a
transferee of an Award shall have no rights as a stockholder with respect to any
shares covered by any award until the date of the issuance of a Company Stock
certificate to him or her for such shares.

            (b)   Determinations by the Committee under the Plan relating to the

                                       18
<PAGE>

form, amount and terms and conditions of grants and Awards need not be uniform,
and may be made selectively among persons who receive or are eligible to receive
grants and awards under the Plan, whether or not such persons are similarly
situated.

21.   Unfunded Status of Awards.

      The Plan is intended to constitute an "unfunded" plan for incentive and
deferred compensation. With respect to any payments not yet made to a
Participant pursuant to an Award, nothing contained in the Plan or any Agreement
shall give any such Participant any rights that are greater than those of a
general creditor of the Company.

22.   No Fractional Shares.

      No fractional shares of Company Stock shall be issued or delivered
pursuant to the Plan. The Committee shall determine whether cash, other Awards,
or other property shall be issued or paid in lieu of such fractional shares or
whether such fractional shares or any rights thereto shall be forfeited or
otherwise eliminated.

23.   Interpretation.

      The Plan is designed and intended to the extent applicable, to comply with
Section 162(m) of the Code, and to provide for grants and other transactions
which are exempt under Rule 16b-3, and all provisions hereof shall be construed
in a manner to so comply.

                                    ********

Approved and adopted by the Board of Directors this 20th day of April, 2004.

                                       19

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00069-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00069-of-00352.parquet"}]]